AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra. AbbVie said it will pay up to about $2.2 billion for the drug GUBamy, which is currently in a Phase 1 ...
China’s box office remained steady over the March 14–16 weekend, with “Ne Zha 2” continuing its dominant run at the top of the charts. The Cococartoon release grossed RMB 148.3 million ($ ...
IPC Indice de Precios Y Cotizaciones 52,674.84 2.42 0.00% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback